Recruitment of Two World-Renowned Bio-Science Experts

Full Launch of the "Global Alpha Class"

Three-Year Lectures, Building International Research Networks, and Advancing the Curriculum

The University of Science and Technology (UST) has recruited two world-renowned experts in the field of bio-science—Professor Raju Kucherlapati and Dr. Palani Palaniappan—as special faculty members. UST will also launch its "Global Alpha Class," an initiative that integrates the world’s top-tier research and industrialization experience into its curriculum.


On June 30, UST announced that it has appointed Raju Kucherlapati, Endowed Professor of Genetics at Harvard Medical School, and Palani Palaniappan, co-founder and CEO of advanced bio startup Aridica, as special faculty members.

Aridica CEO Palani Palaniappan (left), UST President Kang Daeim (center), and Raj K. Kucherlapati, University Professor at Harvard Medical School (right). Courtesy of UST

Aridica CEO Palani Palaniappan (left), UST President Kang Daeim (center), and Raj K. Kucherlapati, University Professor at Harvard Medical School (right). Courtesy of UST

View original image

Recruitment of Leading Global Experts from Basic Research to Industrialization


Professor Raju Kucherlapati is a world-renowned geneticist who led core data production and analysis for "The Cancer Genome Atlas" project. He currently serves as an Endowed Professor of Genetics at Harvard Medical School and Chief of Genetics at Massachusetts General Hospital. He is also a member of the U.S. National Academy of Medicine (NAM). Building on his research achievements, he has founded several biotechnology companies and successfully transferred technology to global pharmaceutical firms, bridging both research and commercialization.


Dr. Palani Palaniappan is an industrial expert who led the development of DNA polymerase, a crucial analytical technology for the success of the Human Genome Project (HGP). He has driven technology development at leading global bio companies such as GE Healthcare and Takeda Pharmaceutical, and he currently serves as co-founder and CEO of the bio startup Aridica. He is also the Chair of the Board at the Drug Information Association (DIA).


Expanding International Research Networks through the Global Alpha Class


For the next three years, both special faculty members will participate in the UST Global Alpha Class and deliver lectures in advanced bio fields. They will also contribute to global talent development programs, including overseas internships, postdoctoral research opportunities, support for international research collaborations, the introduction of advanced curricula, and the establishment of international joint research networks.


In particular, starting on June 30, the two experts will begin active exchanges with students, researchers, and industry professionals by presenting at the UST Global Alpha Class public lecture on "Global Commercialization Strategies and Case Studies of Bio-Innovation Technologies."



Kang Daeim, President of UST, stated, "The appointment of these special faculty members is a core program of the Global Alpha Class, designed for students to learn directly from world-class research experience and insight and to develop capabilities to lead national R&D. We will continue to advance the university’s high-level educational system so that world-class research outcomes generated at national research institutes can drive global industrial innovation."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing